share_log

Earnings Call Summary | Avino Silver & Gold Mines(ASM.US) Q4 2023 Earnings Conference

moomoo AI ·  Mar 21 18:20  · Conference Call

The following is a summary of the Avino Silver & Gold Mines Ltd. (ASM) Q4 2023 Earnings Call Transcript:

Financial Performance:

  • Avino Silver & Gold Mines Ltd. reported Q4 net income of $0.5 million and adjusted earnings of $2 million or $0.02 per share.

  • Q4 revenues were at $12.5 million with full-year revenues almost reaching $44 million.

  • Mine operating income for Q4 was $2.6 million, resulting in a $3.6 million cash operating margin. Full-year mine operating income was at $7.8 million.

  • Cash costs per silver equivalent payable ounce for Q4 and the yearly average were $15 and $15.61 respectively, indicating a decrease from previous quarters in 2023.

Business Progress:

  • Avino announced 2023 Q4 and year-end production with silver equivalent production at 558,000. They plan to process between 700,000 to 750,000 tonnes in 2024.

  • They completed the pre-feasibility study on the Oxide Tailings project, estimating a net present value of US$61 million post-tax, and projecting it as a future asset.

  • A long-term land use agreement was signed for the development of La Preciosa in Durango, Mexico, with capital costs between US$3 million and US$4 million.

  • The company aims to decrease costs over the next two to three years due to higher-grade silver mines coming online and expects to expand production in the next five years to the 7.5 million to 9 million-ounce silver equivalent range.

More details: Avino Silver & Gold Mines IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment